Our associate editors are subspecialty cardiologists selected for deep domain expertise and a commitment to rigorous, timely peer review. Each AE oversees a defined clinical area and manages the review process for manuscripts within their specialty.
TF
Dr. Timothy Fendler
Heart Failure & Cardiomyopathies
Saint Luke's Mid America Heart Institute
Dr. Timothy Fendler is a heart failure and transplant cardiologist at Saint Luke's Mid America Heart Institute, and an emerging national leader in the intersection of palliative care and advanced heart disease. His clinical expertise encompasses device therapy for heart failure, including mechanical circulatory support and LVAD management. Trained at Saint Louis University, the University of Kansas School of Medicine, and Washington University in St. Louis, he completed cardiology, heart failure, and NIH T32 research fellowships before joining Saint Luke's. Dr. Fendler brings exceptional methodological rigor and a patient-centered perspective to his role as Associate Editor.
MI
Dr. Margaret Infeld
Cardiac Electrophysiology
Tufts Medical Center
Dr. Margaret Infeld is a cardiac electrophysiologist at Tufts Medical Center in Boston, with clinical and research expertise spanning arrhythmia management, cardiac pacing, and implantable device therapy. Her research has focused on personalized pacing strategies and the role of heart rate modulation in heart failure with preserved ejection fraction, including the myPACE randomized trial of personalized accelerated pacing. Dr. Infeld brings methodological rigor and a translational perspective on electrophysiology and device-based therapy to her role as Associate Editor.
AS
Dr. Andrew Sauer
Cardiometabolic Health & Clinical Trials
Saint Luke's Mid America Heart Institute
Dr. Andrew Sauer is a cardiologist at Saint Luke's Mid America Heart Institute in Kansas City whose work centers on cardiometabolic health and clinical trials. With additional training in advanced heart failure, he focuses on the cardiovascular care of patients with diabetes, obesity, and metabolic disease, and on the trials shaping cardiometabolic therapeutics — including SGLT2 inhibitors, GLP-1 receptor agonists, and guideline-directed medical therapy. Dr. Sauer brings extensive clinical-trial experience and an integrative, prevention-minded perspective on cardiometabolic care to his role as Associate Editor.
JG
Dr. Jan Griffin
Advanced Heart Failure & Cardiomyopathies
Beth Israel Deaconess Medical Center
Dr. Jan Griffin is an advanced heart failure and transplant cardiologist at Beth Israel Deaconess Medical Center in Boston, with clinical expertise in the management of cardiomyopathies, mechanical circulatory support, and heart transplantation. She completed her training in cardiovascular disease at Johns Hopkins Hospital and in advanced heart failure at Columbia University, and her research has focused on infiltrative cardiomyopathies, particularly cardiac amyloidosis and sarcoidosis. Dr. Griffin brings deep subspecialty expertise in advanced heart failure and a rigorous, patient-focused perspective to her role as Associate Editor.
MY
Dr. Michael Young
Interventional & Structural Heart Disease
Dartmouth-Hitchcock Medical Center
Dr. Michael Young is a board-certified interventional cardiologist at Dartmouth-Hitchcock Medical Center and an Associate Professor of Medicine at the Geisel School of Medicine at Dartmouth. His clinical expertise spans structural heart and peripheral vascular interventions, and he is a leading member of the Dartmouth Health Pulmonary Embolism Response Team. He serves as Director of the Cardiac Catheterization Laboratory and Director of the Structural Heart Disease Program, and is site Principal Investigator for multiple clinical trials enrolling at DHMC. Alongside his procedural practice, Dr. Young brings a keen interest in healthcare delivery science, policy, and outcomes-based research to his role as Associate Editor.
CH
Dr. Chetan Huded
Complex Coronary & Structural Heart Disease
Saint Luke's Mid America Heart Institute
Dr. Chetan Huded is an interventional and structural heart cardiologist at Saint Luke's Mid America Heart Institute in Kansas City, with clinical expertise spanning complex coronary artery disease, acute myocardial infarction, and valvular and structural heart disease. He serves as Medical Director of the Left Atrial Appendage Closure Program, Associate Medical Director of the Structural Heart Program, and Associate Program Director of the Structural Heart Fellowship, and is an Assistant Professor of Medicine at UMKC. He completed internal medicine residency and chief residency at Northwestern's McGaw Medical Center — where he also earned a master's in clinical investigation — followed by cardiology and interventional cardiology fellowships at the Cleveland Clinic, serving as Chief Cardiology Fellow. Dr. Huded brings deep procedural expertise and a clinical-outcomes research perspective to his role as Associate Editor.
SC
Dr. Sunit-Preet “Sonny” Chaudhry
Advanced Heart Failure, MCS & Cardiac Critical Care
Ascension St. Vincent Indianapolis
Dr. Sunit-Preet “Sonny” Chaudhry is an advanced heart failure and transplant cardiologist at Ascension St. Vincent Indianapolis, serving as Medical Director of Mechanical Circulatory Support. His clinical practice centers on cardiogenic shock, temporary and durable mechanical circulatory support, LVAD management, and heart transplantation. Dr. Chaudhry has served as site principal investigator for pivotal heart failure and early-feasibility device trials and contributes to the Critical Care Cardiology Trials Network. He brings the combined perspective of a high-volume trialist and a frontline critical care cardiologist — and a conviction that the status quo is worth challenging — to the role of Associate Editor.
AA
Dr. Alberto Aimo
Heart Failure, Cardiomyopathies & Imaging
Fondazione Toscana Gabriele Monasterio
Dr. Alberto Aimo is a cardiologist at Fondazione Toscana Gabriele Monasterio and a researcher at the Institute of Life Sciences, Scuola Superiore Sant'Anna, in Pisa, Italy. He holds a PhD in translational medicine, and his research spans heart failure and the cardiomyopathies with a focus on circulating biomarkers and multimodality imaging, including cardiac magnetic resonance and nuclear imaging, as tools for diagnosis and prognosis. Dr. Aimo has authored an extensive body of work in this area and has contributed to Heart Failure Association consensus statements. He brings an international, biomarker- and imaging-driven perspective on heart failure and cardiomyopathy to the role of Associate Editor.
NW
Dr. Newton Wiggins
Cardiac Electrophysiology & Arrhythmia Management
University of Mississippi
Dr. Newton Wiggins is a board-certified cardiac electrophysiologist at the University of Mississippi, with clinical expertise spanning atrial fibrillation and complex arrhythmia ablation, cardiac implantable device therapy, and the arrhythmic manifestations of cardiomyopathy. He trained in biological engineering at Mississippi State University before earning his medical degree at the University of Mississippi School of Medicine, and completed internal medicine residency at Duke ahead of cardiovascular disease and clinical cardiac electrophysiology fellowships at the Cleveland Clinic, where he served as Chief Fellow. A Fellow of the American College of Cardiology and the Heart Rhythm Society, Dr. Wiggins brings a proceduralist's perspective and an eye for what actually changes management to his role as Associate Editor.
MI
Dr. Michael Ibrahim
Cardiac Surgery & Valve Reconstruction
University of Virginia Health · Charlottesville, VA
Dr. Michael Ibrahim is a cardiac surgeon at UVA Health in Charlottesville, having joined the cardiac surgery faculty from the University of Pennsylvania, where he served as Director of Mitral and Reconstructive Valve Surgery at Penn Presbyterian Medical Center and as Assistant Professor of Surgery. He read medicine at the University of Cambridge and earned his MBBS and PhD at Imperial College London, and his practice centers on valve repair over replacement — robotic and minimally invasive mitral reconstruction, the Ross operation for aortic valve disease in younger adults, and complex reoperative surgery. His research spans myocardial recovery on durable mechanical circulatory support, heart transplantation, and outcomes after valve reconstruction. Dr. Ibrahim brings a surgeon-scientist's perspective and a bench-to-bedside view of the heart failure and valve literature to his role as Associate Editor.
NS
Dr. Nishant Shah
Preventive Cardiology & Lipid Management
Duke University School of Medicine · Durham, NC
Dr. Nishant Shah is a preventive cardiologist and Associate Professor of Medicine at Duke University School of Medicine, where he practices in the Duke Cardiometabolic Prevention Clinic and is a member of the Duke Clinical Research Institute. He earned his medical degree at Wake Forest, trained in internal medicine in the Osler program at Johns Hopkins, and completed his cardiovascular disease fellowship at the Cleveland Clinic. His clinical and research work centers on advanced lipid management and the genetic biomarkers behind premature coronary disease, alongside remote monitoring and mobile technology for cardiovascular risk reduction; he leads Duke Health's remote lipid monitoring program, serves as associate program director of the cardiovascular medicine fellowship, and co-chairs the American College of Cardiology's cardiometabolic prevention work group. Dr. Shah brings a prevention-first perspective and deep expertise in lipids and cardiovascular risk to his role as Associate Editor.
Associate Editors — Additional Subspecialties
We are actively recruiting associate editors across cardiovascular specialties. Interested in joining the editorial team?
Apply for the Editorial Board →
